Magazine
ENEWS
SUBSCRIBE
WEBINARS
PODCASTS
EBOOKS
Edit submissions
Press releases
Media kit
Innovation Awards
Home
Stem Cell Veto Could Hurt U.S. Competitiveness, Says William Caldwell, CEO of Advanced Cell Technology
June 22, 2007
Caldwell's company is working on stem-cell-based therapies for macular degeneration. Bloomberg TV interviewed him this week for his views. Watch
here.
pharmamanufacturing
Caldwell's company is working on stem-cell-based therapies for macular degeneration. Bloomberg TV interviewed him this week for his views. Watch
here.
About the Author
pharmamanufacturing | pharmamanufacturing
Latest from Home
Anticipating AI regulations in pharma manufacturing
FDA decisions to watch in 2024
5 Pharma changemakers
Raising a modern pharma CDMO
2024 pharma predictions: Regulations, sustainability and culture
Pharma on top for employee pay satisfaction
Load More Content